When does your system generally talk to consumers about lung cancer and smoking cessation? Do you run campaigns in November as part of the Great American Smoke Out? Is it around the New Year? Or whenever a new smoking cessation seminar is being offered?
Smoking cessation is a challenging topic. Nearly every smoker knows they should quit, but it’s a huge lifestyle change. How can you market without offending? Inspire without demotivating? Maybe you can let our assessment help you tailor the message to the individual.
Lung Cancer HRA
Using Medicom’s Lung Cancer Risk Assessment allows you to target users who received a recommendation for a low-dose computer tomography (CT) lung screening. This means men and women aged 55 to 80 years, who have a 30 pack-year smoking history, and currently smoke or who have quit within the past 15 years. (Stop screening once a person has not smoked for 15 years or develops a health problem that limits life expectancy.)
In addition to individuals who smoke, the Lung Cancer Risk Assessment is also useful for those with relevant family history, pulmonary fibrosis, radiation therapy to the chest, second-hand smoke exposure, asbestos, radon, dusts, inhaled chemicals or minerals, workplace exposures or air pollution. This HRA is for people who have NOT already received a lung cancer diagnosis.
As a graduate of the University of Minnesota, Shoua's background in pharmacy, payors, and financial services help her understand the challenges healthcare marketers are facing today.
Her favorite quote is: “If it doesn’t challenge you, you’re not growing.”
Latest posts by Shoua Thao (see all)
- Staff Spotlight:Paul Donnelly – Faster than IT - April 16, 2019
- News:New Bladder Control Health Risk Assessment - April 1, 2019
- Staff Spotlight:Luke Ylvisaker: (prounounced YIL-ve-Sah-ker) - February 18, 2019